MedTrace Logo

Post-ERCP Pancreatitis Severity Indication (PEPSI) Study

NCT03075592 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2019-12-18

No results posted yet for this study

Summary

This study plans to directly address the problem of post-ERCP pancreatitis to gauge the various factors involved in its development and genetic variability in the immune response to an isolated pancreatic insult. In addition, the investigators hope to study markers of the early immune response to this injury and to develop a risk-assessment model.

Conditions

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Georgios I Papachristou, MD · Ohio State University

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-22
Primary Completion
2019-11-22
Completion
2019-11-22

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03075592 on ClinicalTrials.gov